Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
6113613 | Critical Reviews in Oncology/Hematology | 2015 | 6 Pages |
Abstract
Merkel cell nodal carcinoma of unknown primary (MCCUP) is a rare neuroendocrine tumour with distinct clinical and biological behaviour. We conducted a review of retrospective data extracted from 90 patients focusing on the management and outcome of this disease. We also compared life expectancy of these patients with the outcome of patients with known Merkel primaries and with neuroendocrine cancers of unidentifiable primary. There is a limited body of data for this type of malignancy, however, patients with Merkel cell nodal carcinoma of unknown primary site, seem to have better survival when treated aggressively than patients with cutaneous Merkel tumours of the same stage and equal survival with patients with low-grade neuroendocrine tumour of unknown origin. The lack of prospective trials, and the inadequate data, hamper the management of these tumours. Establishment of treatment guidelines is urgently needed.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Hematology
Authors
E.A. Kotteas, N. Pavlidis,